Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02972970 · ClinicalTrials.gov registry record · NA

Feasibility Study to Assess the Scan, Fit and Print Process for the Aveera "Patient Matched" CPAP Mask

A NA study of Obstructive Sleep Apnea, sponsored by Metamason.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT02972970: Completed NA study of Obstructive Sleep Apnea, sponsored by Metamason.

NCT02972970 is a NA study of Obstructive Sleep Apnea that has completed, run by Metamason. The registered enrollment target is 13 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02972970, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Metamason.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

Feasibility study to assess the scan, fit and print process for the Aveera "Patient Matched" CPAP Mask

Primary Outcome

Assess the clinical utility of using a 3D scanning process, printing and fit assessment

Conditions Studied

Interventions

  • DEVICE Aveera

Study Locations (1)

California

  • Tower Sleep Medicine - Los Angeles

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2016-10
Est. Completion 2017-05-16
Phase NA
Metamason

1 total trials

What the finished NCT02972970 record still lists

NCT02972970 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Aveera is the first listed.

NCT02972970 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02972970 about?

NCT02972970 is a clinical study titled "Feasibility Study to Assess the Scan, Fit and Print Process for the Aveera "Patient Matched" CPAP Mask". Feasibility study to assess the scan, fit and print process for the Aveera "Patient Matched" CPAP Mask

What is the current status of trial NCT02972970?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-10. Estimated completion is 2017-05-16.

What conditions does trial NCT02972970 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT02972970?

The interventions under investigation include: Aveera (DEVICE).

Who is sponsoring clinical trial NCT02972970?

This trial is sponsored by Metamason, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02972970 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02972970's enrollment target sits among peer trials

13 150th of 155 higher than 6 of 155 other Obstructive Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02972970, the US trial registry maintained by the National Library of Medicine. NCT02972970 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.